Lonza to Acquire a US Clinical Manufacturing Site to Support Ongoing Customer Demand

Lonza announced today that it is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire plc.

October 3, 2017

1 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal

Lonza announced today that it is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire plc.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like